Parker C. Wilson

Parker C. Wilson

Auto-generated profile, based on publicly available information

Parker C. Wilson

Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YKYuhei Kirita
Yuhei Kirita
HWHaojia Wu
Haojia Wu
KUKohei Uchimura
Kohei Uchimura
PWParker C. Wilson
Parker C. Wilson
BHBenjamin D. Humphreys
Benjamin D. Humphreys
Significance: Single nucleus RNA sequencing revealed gene expression changes during repair after acute kidney injury. We describe a small population of proximal tubule cells that fail to repair (FR-PTCs). Since this subpopulation expresses abundant proinflammatory and profibrotic genes, it may represent a new therapeutic target to improve repair and reduce fibrosis after AKI.

13 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YMYoshiharu Muto
Yoshiharu Muto
PWParker C. Wilson
Parker C. Wilson
NLNicolas Ledru
Nicolas Ledru
HWHaojia Wu
Haojia Wu
HDHenrik Dimke
Henrik Dimke
BHBenjamin D. Humphreys
Benjamin D. Humphreys
The integration of single cell transcriptome and chromatin accessibility datasets enables a deeper understanding of cell heterogeneity. We performed single nucleus ATAC (snATAC-seq) and RNA (snRNA-seq) sequencing to generate paired, cell-type-specific chromatin accessibility and transcriptional profiles of the adult human kidney. We demonstrate that snATAC-seq is comparable to snRNA-seq in the assignment of cell identity and can further refine our understanding of functional heterogeneity in the nephron. The majority of differentially accessible chromatin regions are localized to promoters and a significant proportion are closely associated with differentially expressed genes. Cell-type-specific enrichment of transcription factor binding motifs implicates the activation of NF-κB that promotes VCAM1 expression and drives transition between a subpopulation of proximal tubule epithelial cells. Our multi-omics approach improves the ability to detect unique cell states within the kidney and redefines cellular heterogeneity in the proximal tubule and thick ascending limb.

6 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
PWParker C. Wilson
Parker C. Wilson
YMYoshiharu Muto
Yoshiharu Muto
HWHaojia Wu
Haojia Wu
AKAnil Karihaloo
Anil Karihaloo
SWSushrut S. Waikar
Sushrut S. Waikar
BHBenjamin D. Humphreys
Benjamin D. Humphreys
The proximal tubule is a key regulator of kidney function and glucose metabolism. Diabetic kidney disease leads to proximal tubule injury and changes in chromatin accessibility that modify the activity of transcription factors involved in glucose metabolism and inflammation. Here we use single nucleus RNA and ATAC sequencing to show that diabetic kidney disease leads to reduced accessibility of glucocorticoid receptor binding sites and an injury-associated expression signature in the proximal tubule. We hypothesize that chromatin accessibility is regulated by genetic background and closely-intertwined with metabolic memory, which pre-programs the proximal tubule to respond differently to external stimuli. Glucocorticoid excess has long been known to increase risk for type 2 diabetes, which raises the possibility that glucocorticoid receptor inhibition may mitigate the adverse metabolic effects of diabetic kidney disease.

1 February 2022 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
EDEryn E. Dixon
Eryn E. Dixon
HWHaojia Wu
Haojia Wu
YMYoshiharu Muto
Yoshiharu Muto
PWParker C. Wilson
Parker C. Wilson
BHBenjamin D. Humphreys
Benjamin D. Humphreys
Background: Single-cell sequencing technologies have advanced our understanding of kidney biology and disease, but the loss of spatial information in these datasets hinders our interpretation of intercellular communication networks and regional gene expression patterns. New spatial transcriptomic sequencing platforms make it possible to measure the topography of gene expression at genome depth. Methods: We optimized and validated a female bilateral ischemia-reperfusion injury model. Using the 10× Genomics Visium Spatial Gene Expression solution, we generated spatial maps of gene expression across the injury and repair time course, and applied two open-source computational tools, Giotto and SPOTlight, to increase resolution and measure cell-cell interaction dynamics. Results: An ischemia time of 34 minutes in a female murine model resulted in comparable injury to 22 minutes for males. We report a total of 16,856 unique genes mapped across our injury and repair time course. Giotto, a computational toolbox for spatial data analysis, enabled increased resolution mapping of genes and cell types. Using a seeded nonnegative matrix regression (SPOTlight) to deconvolute the dynamic landscape of cell-cell interactions, we found that injured proximal tubule cells were characterized by increasing macrophage and lymphocyte interactions even 6 weeks after injury, potentially reflecting the AKI to CKD transition. Conclusions: In this transcriptomic atlas, we defined region-specific and injury-induced loss of differentiation markers and their re-expression during repair, as well as region-specific injury and repair transcriptional responses. Lastly, we created an interactive data visualization application for the scientific community to explore these results (http://humphreyslab.com/SingleCell/).

30 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
YMYoshiharu Muto
Yoshiharu Muto
EDEryn E. Dixon
Eryn E. Dixon
YYYasuhiro Yoshimura
Yasuhiro Yoshimura
HWHaojia Wu
Haojia Wu
KOKohei Omachi
Kohei Omachi
BHBenjamin D. Humphreys
Benjamin D. Humphreys
Autosomal dominant polycystic kidney disease (ADPKD) is the leading genetic cause of end stage renal disease characterized by progressive expansion of kidney cysts. To better understand the cell types and states driving ADPKD progression, we analyze eight ADPKD and five healthy human kidney samples, generating single cell multiomic atlas consisting of ~100,000 single nucleus transcriptomes and ~50,000 single nucleus epigenomes. Activation of proinflammatory, profibrotic signaling pathways are driven by proximal tubular cells with a failed repair transcriptomic signature, proinflammatory fibroblasts and collecting duct cells. We identify GPRC5A as a marker for cyst-lining collecting duct cells that exhibits increased transcription factor binding motif availability for NF-κB, TEAD, CREB and retinoic acid receptors. We identify and validate a distal enhancer regulating GPRC5A expression containing these motifs. This single cell multiomic analysis of human ADPKD reveals previously unrecognized cellular heterogeneity and provides a foundation to develop better diagnostic and therapeutic approaches.

8 April 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
PCPing-Min Chen
Ping-Min Chen
PWParker C. Wilson
Parker C. Wilson
JSJustin A. Shyer
Justin A. Shyer
MVMargaret Veselits
Margaret Veselits
HSHolly R. Steach
Holly R. Steach
JCJoe Craft
Joe Craft
The kidney is a frequent target of autoimmune injury, including in systemic lupus erythematosus; however, how immune cells adapt to kidney’s unique environment and contribute to tissue damage is unknown. We found that renal tissue, which normally has low oxygen tension, becomes more hypoxic in lupus nephritis. In the injured mouse tissue, renal-infiltrating CD4+ and CD8+ T cells express hypoxia-inducible factor–1 (HIF-1), which alters their cellular metabolism and prevents their apoptosis in hypoxia. HIF-1–dependent gene-regulated pathways were also up-regulated in renal-infiltrating T cells in human lupus nephritis. Perturbation of these environmental adaptations by selective HIF-1 blockade inhibited infiltrating T cells and reversed tissue hypoxia and injury in murine models of lupus. The results suggest that targeting HIF-1 might be effective for treating renal injury in autoimmune diseases.